Proinflammatory cytokines have been implicated in alcohol-induced neurodegeneration, but the role of the neuroimmune system in alcohol related behaviors has only recently come to the forefront. Herein, the effects of binge-like drinking on IL-1b mRNA and immunoreactivity within the amygdala were measured following the ''drinking in the dark" (DID) paradigm, a model of binge-like ethanol drinking in C57BL/6J mice. Moreover, the role of IL-1 receptor signaling in the amygdala on ethanol consumption was assessed. Results indicated that a history of binge-like ethanol drinking promoted a significant increase of IL-1b mRNA expression within the amygdala, and immunohistochemistry analyses revealed that the basolateral amygdala (BLA), but not central amygdala (CeA), exhibited significantly increased IL-1b immunoreactivity. However, Fluoro-Jade Ò C labeling indicated that multiple cycles of the DID paradigm were not sufficient to elicit neuronal death. Bilateral infusions of IL-1 receptor antagonist (IL-1Ra) reduced ethanol consumption when infused into the BLA but not the CeA. These observations were specific to ethanol drinking as the IL-1Ra did not alter either sucrose drinking or open-field locomotor activity. The current findings highlight a specific role for IL-1 receptor signaling in modulating binge-like ethanol consumption and indicate that proinflammatory cytokines can be induced prior to dependence or any evidence of neuronal cell death. These findings provide a framework in which to understand how neuroimmune adaptations may alter ethanol consumption and therein contribute to alcohol abuse.
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Introduction
Binge drinking is a prevalent problem within the US, and repeated bouts of high blood alcohol concentrations can fundamentally change normal neurobiological functions (CDC, 2013; Gunzerath et al., 2011) . These neuroplastic changes are thought to be one of the underlying mechanisms that lead to alcohol use disorders (AUDs) (Der-Avakian and Markou, 2012). One such system altered by alcohol abuse that has recently emerged as an area of interest is the neuroimmune system (Crews et al., 2011; Hutchinson and Watkins, 2014) . Studies of brains from people with a history of alcohol abuse show increased microglial activation and proinflammatory cytokines such as IL-1b (He and Crews, 2008; Zou and Crews, 2012) . Pre-clinical studies concurring with this phenomenon have mainly focused on characterizing alcohol-induced neuroimmune responses in relation to cellular damage (Crews and Vetreno, 2014; Marshall et al., 2013) or the molecular mechanisms that underlie the initial immune response (FernandezLizarbe et al., 2013) . In particular, IL-1b has been shown to be upregulated in the CNS after various AUD models (Lippai et al., 2013; Qin et al., 2008) . However, the contributions of neuroimmune responses to the modulation of ethanol consumption have been relatively ignored, especially in the transition between alcohol abuse and alcohol dependence. This study utilizes the ''drink ing-in-the-dark" paradigm (DID) because it is uniquely suited to study neuroadaptations that occur during the transitory window of excessive ethanol consumption prior to dependence in rodents (Rhodes et al., 2005; Thiele and Navarro, 2014) .
Studies focused on the alcohol-related behavioral implications of the immune system have shown that modulation of the system alters ethanol consumption. In general, immune activating compounds increase ethanol consumption; whereas, antiinflammatory agents reduce ethanol intake (Bell et al., 2013; Blednov et al., 2011) . For example, peripheral administration of lipopolysaccharide, an inflammatory agent, resulted in prolonged increased voluntary ethanol consumption (Blednov et al., 2011), 
